HIPAA-aware care
Private addiction medicine visits with careful documentation and follow-up.
HIPAA-aware care
Private addiction medicine visits with careful documentation and follow-up.
Licensed providers
Medication decisions are made after clinical review, not by request alone.
Insurance support
Medicaid, Medicare, commercial plans, and self-pay questions can be reviewed.
Same-day access
Fast evaluation may be available when scheduling and clinical safety allow.
The medication conversation changes by substance. Some conditions have established FDA-approved medication options. Others have research interest but no approved medication for routine treatment.
Naltrexone, acamprosate, and disulfiram can be used for selected patients. VIVITROL is an injectable naltrexone option.
Start with medical review, liver and kidney history, opioid exposure, pregnancy questions, and drinking pattern.
FDA-approved options include buprenorphine, methadone, and naltrexone. Suboxone and Sublocade are buprenorphine-based options.
Nao Medical reviews office-based buprenorphine, Suboxone, Sublocade, VIVITROL, naloxone, and referral needs.
FDA-approved options include nicotine replacement therapy, bupropion SR, and varenicline.
Medication choice depends on nicotine pattern, seizure risk, mood history, pregnancy questions, and coverage.
There is no FDA-approved medication for these conditions. Some drugs have been studied, but treatment should not be framed as routine prescribing.
Care can still address counseling, testing, sleep, anxiety, depression, relapse prevention, and referral needs.
Hydrocodone, Vicodin, Percocet, codeine, and OxyContin are opioid pain medications. They can be involved in opioid-use disorder, but they are not medications used to treat opioid-use disorder. FDA-approved medications for opioid-use disorder include buprenorphine, methadone, and naltrexone. Nao Medical focuses on office-based buprenorphine and naltrexone/VIVITROL pathways, plus Sublocade review when appropriate.
Several medications named in research for cocaine, methamphetamine, and cannabis use disorder are not FDA-approved for those conditions. Nao Medical does not present experimental or off-label research drugs as routine addiction treatment. Care can still address cravings, withdrawal discomfort, sleep, anxiety, depression, overdose risk, testing, therapy, and referral needs.
Naltrexone, acamprosate, disulfiram, VIVITROL, counseling, relapse prevention, and safety review.
Suboxone, buprenorphine, Sublocade, VIVITROL, naloxone, fentanyl-aware planning, and follow-up.
Varenicline, bupropion SR, NRT, combination planning, quit support, and insurance questions.
No FDA-approved medication; review research-only questions and practical treatment support.
No FDA-approved medication; review studied options, counseling, sleep, mood, and safety planning.
No FDA-approved medication; review CBD/Epidiolex nuance, gabapentin/pregabalin questions, sleep, anxiety, and therapy.
The provider reviews substance use, withdrawal risk, overdose risk, medical history, current prescriptions, mental health, and treatment goals.
Opioid, alcohol, and tobacco medications have different safety rules. Research-only medications need careful framing and usually are not routine addiction treatment.
Medication is paired with follow-up, counseling, testing when useful, family support when appropriate, and mental-health care when symptoms overlap.
Dose, visit cadence, medication fit, side effects, cravings, relapse risk, and coverage may change as recovery becomes more stable.
Choose a local clinic for addiction medication review, Suboxone or buprenorphine follow-up, alcohol medication discussion, tobacco-cessation medication planning, or coordinated behavioral-health support.
Bronx
932 E 174th St, Bronx, NY 10460
A Bronx access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in West Farms, Crotona Park East, and nearby Bronx neighborhoods.
View local medication support Get directionsQueens
37-15 23rd Ave, Astoria, NY 11105
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Astoria, Ditmars, East Elmhurst, and nearby Queens neighborhoods.
View local medication support Get directions
Bronx
2063A Bartow Ave, Bronx, NY 10475
A Bronx access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Co-op City, Pelham Bay, Baychester, and nearby Bronx neighborhoods.
View local medication support Get directions
Brooklyn
341 Eastern Pkwy, Brooklyn, NY 11216
A Brooklyn access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Crown Heights, Prospect Heights, and nearby Brooklyn neighborhoods.
View local medication support Get directions
Long Island
232 W Old Country Rd, Hicksville, NY 11801
A Long Island access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Hicksville, Plainview, Bethpage, and nearby Nassau County communities.
View local medication support Get directions
Queens
80-10 Northern Blvd, Jackson Heights, NY 11372
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Jackson Heights, Elmhurst, Corona, and nearby Queens neighborhoods.
View local medication support Get directions
Queens
90-18 Sutphin Blvd, Jamaica, NY 11435
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Jamaica, Briarwood, Richmond Hill, and nearby Queens neighborhoods.
View local medication support Get directions
Queens
30-07 36th Ave, Astoria, NY 11106
A Queens access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Long Island City, Astoria, Sunnyside, and nearby Queens neighborhoods.
View local medication support Get directions
Long Island
135 Mineola Blvd, Mineola, NY 11501
A Long Island access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Mineola, Garden City, Westbury, and nearby Nassau County communities.
View local medication support Get directions
Manhattan
259 1st Ave, New York, NY 10003
A Manhattan access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in StuyTown, East Village, Gramercy, and nearby Manhattan neighborhoods.
View local medication support Get directions
Brooklyn
308 Graham Ave, Brooklyn, NY 11211
A Brooklyn access point for addiction medication review, Suboxone or buprenorphine follow-up, alcohol-use medication discussion, tobacco-cessation medication planning, and coordinated behavioral-health support for patients in Williamsburg, Greenpoint, Bushwick, and nearby Brooklyn neighborhoods.
View local medication support Get directionsDaily buprenorphine-naloxone care for opioid-use disorder when clinically appropriate.
Medication review for opioid withdrawal timing, cravings, stabilization, and follow-up.
Monthly injectable buprenorphine review for eligible patients who are already stabilized on buprenorphine.
Naltrexone options for alcohol-use disorder and opioid relapse prevention after opioid-free planning.
Naltrexone, acamprosate, and disulfiram discussion for alcohol-use disorder when appropriate.
Medication works best when paired with counseling, follow-up, relapse planning, and mental-health support.
Support for relatives who need help encouraging care without shame or coercion.
Federal treatment guidance listing medications used for alcohol and opioid use disorders.
FDA guidance identifying buprenorphine, methadone, and naltrexone as approved medications for opioid-use disorder.
CDC guidance on medication treatment, overdose risk, and why detox alone is not recommended for OUD.
CDC guidance on FDA-approved tobacco-cessation medications, including NRT, bupropion SR, and varenicline.
FDA statement that there is currently no FDA-approved medication for stimulant-use disorder.
FDA guidance explaining Epidiolex approvals and that cannabis products are not approved for treating diseases or conditions outside approved indications.
What patients say about Nao Medical
The provider explained which medications were actually approved and which ones were only research questions.
The visit helped me separate Suboxone, Sublocade, VIVITROL, and alcohol medication options.
Insurance questions were handled before I committed to a treatment plan.
The team was direct without making me feel judged.
I appreciated that they did not promise a medication that was not appropriate.
The follow-up plan made the medication decision feel less overwhelming.
Talk with a provider about evidence-based addiction medication, research-only questions, insurance, and follow-up.
Book addiction medicine visit